MedTrace Logo

Patient Enablement in Osteoarthritis - a Longitudinal Study on Patient Education Programs in Primary Health Care

NCT02974036 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 143

Last updated 2022-03-14

No results posted yet for this study

Summary

The overall purpose is to study quality in patient education by means of the patients' self-rated enablement. Specific aims are:

To assess the validity of the patient enablement instrument in relation to self-efficacy and empowerment; To investigate if patient enablement can be effective in identifying which patients would benefit the most from patient education; To study if patient enablement has any relation to self-efficacy, function or self-rated health; To analyze if patient enablement has a causal effect on health care consumption; To evaluate whether patient education is a cost-effective intervention. The project is a longitudinal study, including patients from a patient education programme for osteoarthritis in primary health care. Data consist of patient reported outcome measures and health care consumption. Cost-effectiveness and cost-utility analysis will be used. Inclusion of patients will start August 2016. Analyses of data and manuscript writing will be performed in 2018-2019. Researchers included are from primary health care settings and researchers in the field of OA, patient education and health economy. Our increasingly older and more inactive population will raise huge demands on the health care. The importance of optimizing treatments that are available in primary health care cannot be underestimated. The project will contribute with important knowledge about the patient's own process of getting well.

Conditions

Interventions

OTHER

Patient education for osteoarthritis

Group sessions and optional supervised exercise.

Sponsors & Collaborators

  • Lund University

    lead OTHER

Principal Investigators

  • Eva Ekvall Hansson, Ass prof · Lund University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2019-10-18
Completion
2019-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02974036 on ClinicalTrials.gov